Vernon pastry chefs lure in long lineups for fresh baked treats infotel.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infotel.ca Daily Mail and Mail on Sunday newspapers.
this drug? is a major break there. and i will tell you why. this is a one class of monoclonal antibodies for those of the targeted proteins in your blood, that s directed to get something that is an actual cause. most of the drugs we have been giving patients with dementia and alzheimer s disease have been really related to their symptoms. in trying to recover for example memory or recognition, the qualities. this drug actually goes after something called beta-amyloid which is deposited in the brain. we know it has been in the brain of those with dementia, with alzheimer s disease for many, many years. but now we have a drug that is actually targeting that protein. david: dr. kagan can actually reverse the symptoms or slow the progression of the disease? what is just going to slope the progression of the disease. this drug is approved by the fda. it removes beta ana lloyd rather rapidly in comparison to the